The impact of chronic pain patients' psychotropic drug knowledge and warning labels on the decision whether to drive a car or not

Traffic Inj Prev. 2006 Dec;7(4):360-4. doi: 10.1080/15389580600943005.

Abstract

Objective: The attitudes of patients towards driving a car while taking medication with psychotropic side effects is unclear. A growing number of patients use these psychotropic medicines on a daily basis, and this may interfere with their ability to drive a car.

Methods: By means of a survey, we examined attitudes towards driving while using psychotropic medicinal drugs and the effect of warning labels on the decision whether to drive a car or not in patients with chronic pain.

Results: Fifty-eight of 100 patients possessing a driver's license used psychotropic medication. Despite warning labels affixed on the packages that these drugs might impair driving ability, the majority (71%) of these patients continued driving a car. A point of concern is that 40% of these patients reported not to be more cautious in traffic after taking psychotropic drugs.

Conclusion: The results of this survey indicate that drug warning labels applied by Dutch pharmacies do not significantly change attitudes towards driving a car in patients taking medicinal drugs with psychotropic side effects. Future road-safety campaigns should pay more attention to the impairing effects of psychotropic drugs on driving.

MeSH terms

  • Accidents, Traffic / prevention & control*
  • Adult
  • Automobile Driving / psychology*
  • Automobile Driving / statistics & numerical data
  • Chronic Disease
  • Decision Making*
  • Drug Labeling*
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Male
  • Pain / drug therapy*
  • Psychotropic Drugs / adverse effects*
  • Psychotropic Drugs / therapeutic use
  • Risk Factors
  • Surveys and Questionnaires

Substances

  • Psychotropic Drugs